col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


94 Results       Page 1

 [1] 
The Journal of Rheumatology: The Journal of Rheumatology
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―01 Prevalence and Risk Factors of Post-Acute Sequela of COVID-19 in Adults with Systemic Autoimmune Rheumatic Diseases Mayan S. Teles, Janetta Brundage, Teresa Po-Yu Chiang, Jennifer L. Alejo, Nicolas Henriquez, Rachel Wallwork, et al. (+6)
2 [GO] 2024―Apr―15 When Should I Get My Next COVID Vaccine? Data from the SUrveillance of responses to COVID-19 vaCcines in systEmic immunE mediated inflammatory Diseases (SUCCEED)study Dawn M.E. Bowdish, Vinod Chandran, Carol A. Hitchon, Gilaad G. Kaplan, J. Antonio Avina-Zubieta, Paul R. Fortin, et al. (+24)
3 [GO] 2024―Mar―01 Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Disease Naomi J. Patel, Xiaosong Wang, Miao Lin, Emily N. Kowalski, Claire E. Cook, Kathleen M.M. Vanni, et al. (+12)
4 [GO] 2024―Feb―01 Psoriatic Arthritis and COVID-19 Hinpetch Daungsupawong, Viroj Wiwanitkit
5 [GO] 2024―Feb―01 Additional Reassuring Data for SARS-CoV-2 Vaccination in Immune-Mediated Inflammatory Diseases, but With a Catch Alfred H.J. Kim
6 [GO] 2024―Jan―15 The Future of COVID-19 for Patients With Immune-Mediated Inflammatory Diseases: Who Is at Risk? Cassandra Calabrese
7 [GO] 2024―Jan―15 Role of Creation of Plain Language Summaries to Disseminate COVID-19 Research Findings to Patients With Rheumatic Diseases Mithu Maheswaranathan, Akpabio Akpabio, Laura-Ann Tomasella, Ariella Coler-Reilly, Dawn P. Richards, Richard A. Howard, et al. (+3)
8 [GO] 2023―Oct―15 Breakthrough COVID-19 after tixagevimab/cilgavimab among patients with systemic autoimmune rheumatic diseases Yumeko Kawano, Xiaosong Wang, Naomi J. Patel, Grace Qian, Emily Kowalski, Katarina J. Bade, et al. (+7)
9 [GO] 2023―Oct―01 Safety and Health Care Utilization following COVID-19 Vaccination among Adults with Rheumatoid Arthritis - A population-based self-controlled case series analysis Jennifer J. Y. Lee, Sasha Bernatsky, Jeffrey C. Kwong, Qing Li, Timothy S. H. Kwok, Jessica Widdifield
10 [GO] 2023―Sep―01 Psoriatic Arthritis And Covid-19 - Patient Perspectives In A Large Psoriatic Arthritis Cohort Neda Pirouzmand, Daniel Pereira, Mitchell Sutton, Ashish J. Mathew, Vinod Chandran, Dafna D. Gladman
11 [GO] 2023―Aug―01 Impact of COVID-19 on Patients With Psoriasis or Psoriatic Arthritis Philip J. Mease, Peter Nash, Suzanne Grieb, Vinod Chandran
12 [GO] 2023―Jul―15 Sex in the Time of COVID-19 Mark Harrison
13 [GO] 2023―Jun―15 The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort Philippa D.K. Curry, Hector Chinoy, Meghna Jani, Darren Plant, Kimmie L. Hyrich, Ann W. Morgan, et al. (+5)
14 [GO] 2023―May―01 Molnupiravir and Nirmatelvir/Ritonavir in the Treatment of Patients With Systemic Autoimmune Rheumatic Disease With SARS-CoV-2 Kelly Corbitt, Peter Izmirly, Amit Saxena
15 [GO] 2023―Mar―15 Biologic sex inequality in rheumatology wait times during the COVID-19 pandemic Steven J. Katz, Carrie Ye
16 [GO] 2023―Mar―15 COVID-19 Vaccination as a Trigger of IgA Vasculitis: Truth or Illusion? Gang Wang, Ying Luo, Bihui Li, Jie Li
17 [GO] 2023―Feb―01 Importance of SARS-CoV-2 Spike Antibodies and B Cell Reconstitution to Optimize the Prevention Strategy of COVID-19 Marion Thomas, Jérôme Avouac
18 [GO] 2023―Jan―15 Preferences for COVID-19 vaccination in people with chronic immune-mediated inflammatory diseases Glen S. Hazlewood, Ines Colmegna, Carol Hitchon, Paul R. Fortin, Sasha Bernatsk, Ann E. Clarke, et al. (+9)
19 [GO] 2023―Jan―15 Comparative effectiveness of BNT162b2 and mRNA-1273 vaccines against COVID-19 infection among patients with systemic autoimmune rheumatic diseases on immunomodulatory medications Claire Cook, Naomi J. Patel, Xiaoqing Fu, Xiaosong Wang, Yumeko Kawano, Kathleen M.M. Vanni, et al. (+7)
20 [GO] 2022―Dec―15 COVID-19 and IgA Vasculitis Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
21 [GO] 2022―Dec―15 B-cell reconstitution is associated with COVID-19 booster vaccine responsiveness in previously seronegative rituximab treated patients Kaitlin Schultz, Deanna Jannat-Khah, Robert Spiera
22 [GO] 2022―Dec―15 COVID-19 Disrupts Rheumatology Care: An Opportunity for Innovation? Rebecca Grainger, Valerie Milne
23 [GO] 2022―Dec―15 Oral antiviral treatment for COVID-19 in patients with systemic autoimmune rheumatic diseases Nafsika Gerolymatou, Athanasios-Dimitrios Bakasis, Paraskevi V. Voulgari, Panayiotis G. Vlachoyiannopoulos
24 [GO] 2022―Dec―15 COVID-19 vaccination perceptions in rheumatology patients: a cross-sectional online survey Imama Noor Butt, Charmaine van Eeden, Katharina Kovacs Burns, Lynora Saxinger, Alison Clifford, Jan Willem Cohen Tervaert, Elaine Yacyshyn
25 [GO] 2022―Dec―01 Impact Factor Jumps After the 2020 COVID-19 Pandemic: A Retrospective Study in Rheumatology Journals Abril-Carolina Mendoza-Lopez, Leslie-Marisol Gonzalez-Hermosillo, Ernesto Roldan-Valadez
26 [GO] 2022―Nov―15 COVID-19 vaccination as a trigger of IgA vasculitis: a global pharmacovigilance study Yanis Ramdani, Bérenger Largeau, Annie-Pierre Jonville-Bera, François Maillot, Alexandra Audemard-Verger
27 [GO] 2022―Nov―15 Prevalence, risk factors, and outcomes of gout flare in patients hospitalized for PCR-confirmed COVID-19: A multicenter retrospective cohort study Kanon Jatuworapruk, Panchalee Satpanich, Philip C. Robinson, Rebecca Grainger
28 [GO] 2022―Nov―01 IgA vasculitis following COVID-19 vaccination: A French multicentre case series including 12 patients Yanis Ramdani, Thomas Bettuzzi, Amel Bouznad, Léa Delaitre, Kladoum Nassarmadji, Kevin Didier, et al. (+10)
29 [GO] 2022―Oct―15 The Third Dose Is the Charm: Effective Cellular and Humoral Immune Responses to Third COVID-19 Vaccine Doses in Immunosuppressed Nonresponders Wilson Kuswanto, Matthew C. Baker
30 [GO] 2022―Oct―01 Trend in industry payments to rheumatologists in the United States during the COVID-19 pandemic between 2013 and 2021 Anju Murayama, Sae Kamamoto, Kenichi Higuchi, Haruki Shigeta, Akihiko Ozaki
31 [GO] 2022―Oct―01 Changes in service delivery and access to rheumatologists pre- and during the COVID-19 pandemic in a Canadian universal healthcare setting Timothy S.H. Kwok, Bindee Kuriya, Lauren K King, Lihi Eder, Carter Thorne, Zhiyin Li, et al. (+4)
32 [GO] 2022―Oct―01 Livedo reticularis after COVID-19 vaccination Taro Horino, Satoshi Inotani, Kimiko Nakajima, Yoshio Terada
33 [GO] 2022―Oct―01 Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines Carolina A. Isnardi, Osvaldo L. Cerda, Margarita Landi, Leonel Cruces, Emilce E. Schneeberger, Claudia Calle Montoro, et al. (+24)
34 [GO] 2022―Sep―01 IgA vasculitis following COVID-19: a French multicentric case-series Yanis Ramdani, Jean-Marc Galempoix, Jean François Augusto, Eva Dekmeer, Laurent Perard, Nicole Ferreira, et al. (+8)
35 [GO] 2022―Sep―01 From Canadian Living Guidelines to Global Living Guidelines: A Post Pandemic Effort Ines Colmenga, Michael E. Weinblatt
36 [GO] 2022―Aug―15 Adult-Onset Still Disease After ChadOx1 nCOV-19 Vaccination Jian Weng, Linghong Linda Zhou, Thomas Hahn, Kamran Shojania, Jan Dutz
37 [GO] 2022―Aug―01 Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association? Anastasios Karamanakos, Gerasimos Evangelatos, Maria Pappa, Kalliopi Fragiadaki, Antonis Fanouriakis, George E. Fragoulis
38 [GO] 2022―Jul―01 COVID-19 vaccine uptake among patients with systemic lupus erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN) Baptiste Chevet, Gabriel Figueroa-Parra, Jeffrey X. Yang, Cassondra A. Hulshizer, Tina M. Gunderson, Stephanie Q. Duong, et al. (+4)
39 [GO] 2022―Jun―15 Anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease after vaccination with COVID-19 mRNA vaccines Takamasa Kitajima, Atsushi Funauchi, Toshiki Nakajima, Satoshi Marumo, Yoshitaka Imura, Motonari Fukui
40 [GO] 2022―Jun―15 Evaluation of patients with rheumatoid arthritis in teleconsultation during the first wave of the COVID-19 pandemic Jérôme Avouac, Anna Molto, Camélia Frantz, Sarah Wanono, Elise Descamps, Olivier Fogel, et al. (+4)
41 [GO] 2022―Jun―15 Long-term behavioral changes during the COVID-19 pandemic and impact of vaccination in patients with inflammatory rheumatic diseases Bente Glintborg, Dorte Vendelbo Jensen, Lene Terslev, Oliver Hendricks, Mikkel Østergaard, Simon Horskjær Rasmussen, et al. (+14)
42 [GO] 2022―Apr―15 Post SARS-CoV-2 Vaccine Chilblains-like Lesions Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
43 [GO] 2022―Mar―01 Time since rituximab treatment is essential for developing a humoral response to COVID-19 mRNA vaccines in patients with rheumatic diseases Anne Troldborg, Marianne Kragh Thomsen, Lars Erik Bartels, Jakob Bøgh Andersen, Signe Risbøl Vils, Clara Elbæk Mistegaard, et al. (+6)
44 [GO] 2022―Mar―01 COVID-19 Update for the GRAPPA 2021 Annual Meeting: Focus on COVID-19 Vaccination Philip J. Mease, Kevin Winthrop, Wendy Olsder, Jeffrey R. Curtis
45 [GO] 2022―Mar―01 Immunogenicity of COVID-19 vaccination in patients with ankylosing spondylitis: a monocentric prospective belgian cohort study Tracy Vandergraesen, Leila Mekkaoui, Hafid Dahma, Muhammad Soyfoo, Laure Tant
46 [GO] 2022―Feb―01 Telemedicine Use During the COVID-19 Pandemic by Resilient Rheumatology Providers: A National Veterans Affairs Follow-up Survey Jasvinder A. Singh, John S. Richards, Elizabeth Chang, Amy M. Joseph, Bernard Ng
47 [GO] 2022―Feb―01 Impaired humoral immunogenicity of SARS-CoV-2 vaccination in rheumatoid arthritis patients Camille Le Moine, Muhammad Shahnawaz Soyfoo, Leila Mekkaoui, Hafid Dahma, Laure Tant
48 [GO] 2022―Feb―01 COVID-19 hospitalizations, intensive care unit stays, ventilation and death among patients with immune mediated inflammatory diseases compared to controls Lihi Eder, Ruth Croxford, Aaron M. Drucker, Arielle Mendel, Bindee Kuriya, Zahi Touma, et al. (+5)
49 [GO] 2022―Jan―15 COVID-19 Vaccination Uptake among individuals with Immune-Mediated Inflammatory Diseases in Ontario, Canada between December 2020 and October 2021: A population-based analysis Jessica Widdifield, Lihi Eder, Simon Chen, Jeffrey C. Kwong, Carol Hitchon, Diane Lacaille, et al. (+3)
50 [GO] 2022―Jan―15 Safety profile and low risk of disease relapse after BNT162b2 mRNA SARS-COV-2 vaccination in patients with rare rheumatic diseases Marco Fornaro, Vincenzo Venerito, Florenzo Iannone, Fabio Cacciapaglia
51 [GO] 2021―Dec―15 Vasculitis As Temporally Associated With COVID-19 Infection or Vaccination: A Single-center Experience Alojzija Hočevar, Zoran Simonović, Žiga Rotar, Matija Tomšič
52 [GO] 2021―Nov―15 Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients with Autoimmune Conditions Treated with Systemic Therapies: a Population-based Study Jeffrey R. Curtis, Xiaofeng Zhou, David T. Rubin, Walter Reinisch, Jinoos Yazdany, Philip C. Robinson, et al. (+4)
53 [GO] 2021―Nov―01 COVID-19 in Children With Rheumatic Diseases in the Spanish National Cohort EPICO-AEP Cristina Calvo, Clara Udaondo
54 [GO] 2021―Oct―15 The Effect of COVID-19 Illness on Pregnant Patients With Rheumatic Disease: Early Reassuring Data Lisa R. Sammaritano
55 [GO] 2021―Oct―15 Impact of COVID-19 pandemic on appropriateness of diagnostic pathways of autoimmune diseases Teresa Carbone, Valentina Picerno, Vito Pafundi, Ernesto Esposito, Pietro Leccese, Angela Padula, Salvatore D'Angelo
56 [GO] 2021―Oct―15 Improving COVID-19 vaccine coverage in patients with autoimmune and inflammatory diseases Tiphaine Goulenok, Chrystelle Francois, Céline Mendes, Fatima Farhi, Jean-Francois Alexandra, Diane Rouzaud, et al. (+2)
57 [GO] 2021―Oct―01 The Interplay between Covid-19 and Spondyloarthritis or Its Treatment James T. Rosenbaum, Michael H. Weisman, Hedley Hamilton, Cassie Shafer, Elin Aslanyan, Richard A. Howard, et al. (+4)
58 [GO] 2021―Oct―01 Case of Giant Cell Arteritis After SARS-CoV-2 Vaccination: A Particular Phenotype? Agathe Sauret, Julien Stievenart, Perrine Smets, Louis Olagne, Benedicte Guelon, Olivier Aumaître, et al. (+2)
59 [GO] 2021―Sep―01 COVID-19 in women with rheumatic disease who are pregnant: Data from the COVID-19 Global Rheumatology Alliance Bonnie L. Bermas, Milena Gianfrancesco, Helen L. Tanner, Andrea M. Seet, Mathia C. Aguiar, Nasra K. Al Adhoubi, et al. (+32)
60 [GO] 2021―Aug―01 The COVID-19 Pandemic and Rheumatology: Impact on Providing Care in Latin America and Around the World Sebastian E. Sattui, Philip C. Robinson
61 [GO] 2021―Jul―01 A Case of Chilblains-like Lesions Post SARS-CoV-2 Vaccine? Alexa Simon Meara, Molly Silkoski,, Kai Quin, Wael Jarjour
62 [GO] 2021―Jun―15 Impact of COVID-19 pandemic on rheumatology practice in Latin America Daniel G. Fernández-Ávila, Julián Barahona-Correa, Diana Romero-Alvernia, Sergio Kowalski, Ana Sapag, Antonio Cachafeiro-Vilar, et al. (+16)
63 [GO] 2021―Jun―01 The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know Katie Bechman, Mrinalini Dey, Mark Yates, Marwan Bukhari, Kevin Winthrop, James B. Galloway
64 [GO] 2021―May―15 Canadian Rheumatology Association recommendation for the use of COVID-19 vaccination for patients with autoimmune rheumatic diseases Glen S. Hazlewood, Jordi Pardo, Cheryl Barnabe, Orit Schieir, Claire E.H. Barber, Sasha Bernatsky, et al. (+16)
65 [GO] 2021―Mar―15 Risk of severe coronavirus infection (COVID-19) in patients with inflammatory rheumatic diseases. Javier Bachiller-Corral, Alina Boteanu, Maria Jesus Garcia-Villanueva, Carlos de la Puente, Marcelino Revenga, M. Consuelo Diaz-Miguel, et al. (+10)
66 [GO] 2021―Mar―15 Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting Philip J. Mease, Leonard H. Calabrese, Kristina Callis Duffin, Rebecca H. Haberman, Rodrigo Firmino, Jose U. Scher, et al. (+3)
67 [GO] 2021―Mar―01 COVID-19 and Rheumatic Diseases: It Is Time to Better Understand This Association Claudia D.L. Marques
68 [GO] 2021―Feb―15 Re-thinking Physical Activity Promotion during COVID-19 Pandemic: Focus on a 24-hour Day Linda C. Li, Lynne M. Feehan, Alison M. Hoens
69 [GO] 2021―Feb―01 Covid-19 in Children with Rheumatic Diseases in the Spanish National Cohort EPICO-AEP Cristina Calvo, Clara Udaondo
70 [GO] 2020―Dec―01 Infection or autoimmunity? The clinical challenge of interstitial lung disease in systemic sclerosis during COVID 19 pandemic Martina Orlandi, Nicholas Landini, Cosimo Bruni, Stefano Colagrande, Marco Matucci-Cerinic, Musataka Kuwana
71 [GO] 2020―Nov―15 Concerns, healthcare use, and treatment interruptions in patients with common autoimmune rheumatic diseases during the COVID-19 pandemic Michael George, Shilpa Venkatachalam, Shubhasree Banerjee, Joshua F. Baker, Peter A. Merkel, Kelly Gavigan, et al. (+4)
72 [GO] 2020―Nov―01 Risk of Adverse Outcomes in Hospitalized Patients with Autoimmune Disease and COVID-19: A Matched Cohort Study from New York City Adam S. Faye, Kate E. Lee, Monika Laszkowska, Judith Kim, John William Blackett, Anna S. McKenney, et al. (+8)
73 [GO] 2020―Oct―15 The Effect of HLA-B27 on Susceptibility and Severity of COVID-19 James T. Rosenbaum, Hedley Hamilton, Michael H. Weisman, John D. Reveille, Kevin L. Winthrop, Dongseok Choi
74 [GO] 2020―Oct―15 Giant Cell Arteritis and COVID-19: Similarities and Discriminators. A Systematic Literature Review Puja Mehta, Sebastian E. Sattui, Kornelis S.M. van der Geest, Elisabeth Brouwer, Richard Conway, Michael S. Putman, et al. (+2)
75 [GO] 2020―Sep―15 Covid-19 in Patients with Connective Tissue Disease-Related Interstitial Lung Disease Linh Troung, Lila Pourzand, Elizabeth R. Volkmann
76 [GO] 2020―Sep―15 Attitudes and Behaviours of Patients with Rheumatic Diseases during the early stages of the COVID-19 Outbreak. Margaret H.Y. Ma, Sen Hee Tay, Peter P.M. Cheung, Amelia Santosa, Yiong Huak Chan, James W.L. Yip, et al. (+2)
77 [GO] 2020―Aug―15 Walk at least 10 minutes a day for adults with knee OA: Recommendation for minimal activity during the COVID-19 pandemic Jason T. Jakiela, Esther J. Waugh, Daniel K. White
78 [GO] 2020―Jul―01 Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in synovial tissues Sho Mokuda, Tadahiro Tokunaga, Junya Masumoto, Eiji Sugiyama
79 [GO] 2020―Jun―08 Rheumatologists and Pulmonologists at Temple University weather the COVID-19 storm together Roberto Caricchio, Gerard J. Criner
80 [GO] 2020―Jun―08 Teamwork, A Novel Concept During an Infectious Pandemic? Randy Q. Cron, W. Winn Chatham
81 [GO] 2020―Jun―01 No SLE with COVID-19 in Hong Kong: the effect of masking? Ho So, Joyce Wing Yan Mak, Lai-shan Tam
82 [GO] 2020―Jun―01 Are patients with systemic lupus erythematosus at increased risk of severe COVID-19? Ennio Giulio Favalli, Elena Agape, Roberto Caporali
83 [GO] 2020―May―25 Evidence of protective effect of hydroxychloroquine to prevent COVID-19 Beuy Joob, Viroj Wiwanitkit
84 [GO] 2020―May―25 Treating Covid-19 at the Inflection Point W. Winn Chatham, Randy Q. Cron
85 [GO] 2020―May―25 SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets - What to learn from Rheumatologists? Carlos Antonio Mouraa, Ana Luísa Cerqueira de Sant’Ana Costa
86 [GO] 2020―May―18 COVID-19 and Rheumatology patients on immunomodulatory therapy - can we extrapolate data from previous viral pandemics? Hannah Jethwa, Ann Sullivan, Sonya Abraham
87 [GO] 2020―May―11 Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials Stephen J. Balevic, Christoph P. Hornik, Thomas P. Green, Megan E.B. Clowse, Daniel Gonzalez, Anil R. Maharaj, et al. (+5)
88 [GO] 2020―Apr―25 Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis Ennio Giulio Favalli, Elena Agape, Roberto Caporali
89 [GO] 2020―Apr―25 The Question of Whether to Remain on Therapy for Chronic Rheumatic Diseases in the Setting of the Covid-19 Pandemic Randy Q. Cron, W. Winn Chatham
90 [GO] 2020―Apr―25 Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs Giovanni Filocamo, Francesca Minoia, Simone Carbogno, Stefania Costi, Micol Romano, Rolando Cimaz
91 [GO] 2020―Apr―08 Learning from Adversity: Lessons from the COVID-19 Crisis Michael S. Putman, Eric M. Ruderman
92 [GO] 2020―Apr―08 Possible Consequences of a Shortage of Hydroxychloroquine for Lupus Patients Amid the COVID-19 Pandemic Christine A. Peschken
93 [GO] 2020―Apr―02 Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic Rosie Scuccimarri, Evelyn Sutton, Mary-Ann Fitzcharles
94 [GO] 2020―Mar―24 The Rheumatologist’s Role in Covid-19 Randy Q. Cron, W. Winn Chatham
 [1] 

94 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec